Skip to main content
SpringerLink
Log in

Diabetic Retinopathy: Pathogenesis, Treatment, and Complications

  • Chapter
  • First Online:
Drug Delivery for the Retina and Posterior Segment Disease

Abstract

Diabetic retinopathy is a complication of diabetes. Majority of diabetic patients with high blood glucose face the challenge of dealing with retinopathy and macular edema as the disease progresses. Although treatment choices and care are available to manage and symptomatically treat Diabetic retinopathy the current understanding is limited and lacks options for treatment and rescue strategies. Pharmacological options include anti-VEGF treatment strategies and surgical procedures. The present review provides insights in to type of diabetic retinopathy, along with different stages of the disease. In addition, the roles for health care providers, importance of pharmacists for treatment and management of diabetic retinopathy patient care are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Colquitt J, Jones J, Tan S, Takeda A, Clegg A, Price A. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess. 2008;12(16):iii.

    Article  CAS  Google Scholar 

  2. Spooner K, Hong T, Wijeyakumar W, Chang AA. Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis. Clin Ophthalmol. 2017;Volume 11:161–77.

    Article  Google Scholar 

  3. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38(10):1203–6.

    Article  CAS  Google Scholar 

  4. Bresnick GH, Venecia GD, Myers FL, Harris JA, Davis MD. Retinal ischemia in diabetic retinopathy. Arch Ophthalmol. 1975;93(12):1300–10.

    Article  CAS  Google Scholar 

  5. Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology. 1993;100(8):1133–9.

    Article  CAS  Google Scholar 

  6. Bandello F, Lattanzio R, Zucchiatti I, Petruzzi G. Non-proliferative diabetic retinopathy. In: Clinical strategies in the management of diabetic retinopathy. Springer-Verlag: Berlin Heidelberg; 2014. p. 19–63.

    Google Scholar 

  7. Shah KB, Han DP. Proliferative diabetic retinopathy. Int Ophthalmol Clin. 2004;44(4):69–84.

    Article  Google Scholar 

  8. Ivanisevic M. Stage M1: Maculopathy. A practical manual of diabetic retinopathy management; 2009. p. 70–98.

    Google Scholar 

  9. Dowler JGF. Laser management of diabetic retinopathy. J R Soc Med. 2003;96(6):277–9.

    Article  Google Scholar 

  10. Schwartz SG, Flynn HW. Pars plana vitrectomy for primary rhegmatogenous retinal detachment. Clin Ophthalmol. 2008;2:57.

    Article  Google Scholar 

  11. Cleary PE. The treatment of advanced diabetic eye disease. Ir J Med Sci. 1979;148(S2):38–44.

    Article  Google Scholar 

  12. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283(7):889.

    Article  CAS  Google Scholar 

  13. Macha S, Hughes P, Mitra A. Overview of ocular drug delivery. In: Ophthalmic drug delivery systems, vol. 25. 2nd ed. New York: Dekker; 2003. p. 1–12.

    Google Scholar 

  14. Grisanti S, Ziemssen F. Bevacizumab: off-label use in ophthalmology. Indian J Ophthalmol. 2007;55(6):417.

    Article  Google Scholar 

  15. Waisbourd M, Goldstein M, Loewenstein A. Treatment of diabetic retinopathy with anti-VEGF drugs. Acta Ophthalmol. 2010;89(3):203–7.

    Article  Google Scholar 

  16. Schmucker C, Ehlken C, Agostini HT, Antes G, Ruecker G, Lelgemann M, Loke YK. A safety review and meta-analyses of bevacizumab and Ranibizumab: off-label versus Goldstandard. PLoS One. 2012;7(8):e42701.

    Article  CAS  Google Scholar 

  17. Abraham A, Senthil S. Clinical ophthalmology: made easy. New Delhi: Jaypee Brothers Medical Publishers; 2013.

    Book  Google Scholar 

  18. Galvez MIL. Protein kinase C inhibitors in the treatment of diabetic retinopathy. Review. Curr Pharm Biotechnol. 2011;12(3):386–91.

    Article  CAS  Google Scholar 

  19. Augustin A. Anecortave acetate in the treatment of age-related macular degeneration. Clin Interv Aging. 2006;1(3):237–46.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, USF College of Pharmacy, Tampa, FL, USA

    Samhitha Gudla & Srinivas M. Tipparaju

  2. Sri Ramachandra Medical College and Research Institute, Bangalore, India

    Divya Tenneti

  3. University of South Florida, Tampa, FL, USA

    Makrand Pande

  4. College of Pharmacy, University of South Florida, Tampa, FL, USA

    Srinivas M. Tipparaju

Authors
  1. Samhitha Gudla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Divya Tenneti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Makrand Pande
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Srinivas M. Tipparaju
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Srinivas M. Tipparaju .

Editor information

Editors and Affiliations

  1. Faculty of Pharmacy, Sankalchand Patel University, Gujarat, India

    Jayvadan K. Patel

  2. College of Pharmacy, University of South Florida, Tampa, FL, USA

    Vijaykumar Sutariya

  3. School of Medicine, Faculty of Health, Deakin University, Victoria, Australia

    Jagat Rakesh Kanwar

  4. College of Pharmacy, University of South Florida, Tampa, FL, USA

    Yashwant V. Pathak

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gudla, S., Tenneti, D., Pande, M., Tipparaju, S.M. (2018). Diabetic Retinopathy: Pathogenesis, Treatment, and Complications. In: Patel, J., Sutariya, V., Kanwar, J., Pathak, Y. (eds) Drug Delivery for the Retina and Posterior Segment Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-95807-1_5

Download citation

Publish with us

Policies and ethics

Search

Navigation